• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测一氧化碳暴露导致的碳氧血红蛋白水平。

Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposures.

作者信息

Peterson J E, Stewart R D

出版信息

J Appl Physiol. 1975 Oct;39(4):633-8. doi: 10.1152/jappl.1975.39.4.633.

DOI:10.1152/jappl.1975.39.4.633
PMID:1194155
Abstract

Data from a series of human exposures to carbon monoxide (CO) were analyzed to determine the fit to the theoretical Coburn-Forster-Kane (CFK) equation which describes CO absorption and excretion. The equation was found to predict carboxyhemoglobin (HbCO) saturations for both men and women at exercise rates ranging from sedentary to 300 kpm/min when they were exposed to steady CO concentrations of 50, 100, and 200 ppm for 0.33-5.25 h. Methods for determining values of each of the variables in the CFK equation were collected and a rational, efficient procedure for solving the equation by trial and error was outlined. The CFK equation was then used to prepare a graph, relating HbCO saturation to exposure duration and concentration, and also to describe the effect of several variables on the rate of CO uptake and equilibrium HbCO levels, important considerations in the determination of permissible public, occupational, and experimental exposure to CO.

摘要

分析了一系列人体一氧化碳(CO)暴露的数据,以确定其与描述CO吸收和排泄的理论科伯恩-福斯特-凯恩(CFK)方程的拟合情况。结果发现,当男性和女性在0.33 - 5.25小时内暴露于50、100和200 ppm的稳定CO浓度下,该方程能够预测从久坐到300 kpm/分钟运动速率下的碳氧血红蛋白(HbCO)饱和度。收集了确定CFK方程中每个变量值的方法,并概述了一种通过试错法求解该方程的合理、有效程序。然后使用CFK方程绘制了一张图表,将HbCO饱和度与暴露持续时间和浓度联系起来,还描述了几个变量对CO摄取速率和平衡HbCO水平的影响,这是确定公众、职业和实验中允许的CO暴露时的重要考虑因素。

相似文献

1
Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposures.预测一氧化碳暴露导致的碳氧血红蛋白水平。
J Appl Physiol. 1975 Oct;39(4):633-8. doi: 10.1152/jappl.1975.39.4.633.
2
Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.基于生理学的大鼠和人体二氯甲烷、其代谢物、一氧化碳及血液碳氧血红蛋白的药代动力学建模
Toxicol Appl Pharmacol. 1991 Mar 15;108(1):14-27. doi: 10.1016/0041-008x(91)90264-f.
3
Rate of formation of carboxyhemoglobin in exercising humans exposed to carbon monoxide.暴露于一氧化碳的运动人群中碳氧血红蛋白的形成速率。
J Appl Physiol (1985). 1992 Apr;72(4):1311-9. doi: 10.1152/jappl.1992.72.4.1311.
4
Carbon monoxide uptake and excretion: testing assumptions made in deriving the Coburn-Forster-Kane equation.一氧化碳摄取与排泄:对考本-福斯特-凯恩方程推导中所作假设的检验。
Respir Physiol Neurobiol. 2013 Jul 1;187(3):224-33. doi: 10.1016/j.resp.2013.04.006. Epub 2013 Apr 17.
5
A multicompartment model of carboxyhemoglobin and carboxymyoglobin responses to inhalation of carbon monoxide.一氧化碳吸入后碳氧血红蛋白和碳氧肌红蛋白反应的多室模型
J Appl Physiol (1985). 2003 Sep;95(3):1235-47. doi: 10.1152/japplphysiol.00217.2003. Epub 2003 May 16.
6
Modeling carbon monoxide uptake during work.模拟工作期间一氧化碳的摄取情况。
Am Ind Hyg Assoc J. 1981 May;42(5):361-4. doi: 10.1080/15298668191419884.
7
Comparing solutions to the linear and nonlinear CFK equations for predicting COHb formation.比较用于预测碳氧血红蛋白(COHb)形成的线性和非线性CFK方程的解。
Math Biosci. 1990 May;99(2):251-63. doi: 10.1016/0025-5564(90)90007-l.
8
Prediction of carboxyhemoglobin formation due to transient exposure to carbon monoxide.短暂接触一氧化碳导致的碳氧血红蛋白形成的预测。
J Appl Physiol (1985). 1994 Apr;76(4):1739-45. doi: 10.1152/jappl.1994.76.4.1739.
9
Percent carboxyhemoglobin in resting humans exposed repeatedly to 1,500 and 7,500 ppm CO.
J Appl Physiol (1985). 1987 Aug;63(2):820-7. doi: 10.1152/jappl.1987.63.2.820.
10
Carboxyhemoglobin formation due to carbon monoxide exposure in rats.大鼠因接触一氧化碳而形成碳氧血红蛋白。
Toxicol Appl Pharmacol. 1994 Sep;128(1):151-7. doi: 10.1006/taap.1994.1192.

引用本文的文献

1
Does traffic-related air pollution exposure alter blood gas parameters in recreationally trained male cyclists during prolonged endurance exercise?在长时间耐力运动期间,与交通相关的空气污染暴露会改变休闲训练的男性自行车运动员的血气参数吗?
Physiol Rep. 2025 Jun;13(11):e70408. doi: 10.14814/phy2.70408.
2
Carboxyhemoglobin half-life toxicokinetic profiles during and after normobaric oxygen therapy: On a swine model.常压氧疗期间及之后碳氧血红蛋白半衰期的毒代动力学概况:以猪模型为例。
Toxicol Rep. 2024 Feb 23;12:271-279. doi: 10.1016/j.toxrep.2024.02.005. eCollection 2024 Jun.
3
"CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.
“药丸中的 CO”:迈向一氧化碳的口服递送用于治疗应用。
J Control Release. 2021 Oct 10;338:593-609. doi: 10.1016/j.jconrel.2021.08.059. Epub 2021 Sep 2.
4
Endogenous Carbon Monoxide Production and Diffusing Capacity of the Lung for Carbon Monoxide in Sepsis-Induced Acute Respiratory Distress Syndrome.脓毒症诱导的急性呼吸窘迫综合征中内源性一氧化碳生成及肺一氧化碳弥散能力
Crit Care Explor. 2020 Dec 2;2(12):e0286. doi: 10.1097/CCE.0000000000000286. eCollection 2020 Dec.
5
Factors Contributing to CO Uptake and Elimination in the Body: A Critical Review.影响机体 CO 摄取和清除的因素:一项关键性综述。
Int J Environ Res Public Health. 2020 Jan 14;17(2):528. doi: 10.3390/ijerph17020528.
6
Carbon monoxide in intensive care medicine-time to start the therapeutic application?!重症医学中的一氧化碳——是时候开始治疗应用了吗?
Intensive Care Med Exp. 2020 Jan 9;8(1):2. doi: 10.1186/s40635-020-0292-8.
7
A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS.一项低剂量吸入一氧化碳治疗脓毒症相关性急性呼吸窘迫综合征的 I 期临床试验。
JCI Insight. 2018 Dec 6;3(23):124039. doi: 10.1172/jci.insight.124039.
8
Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.吸入一氧化碳对肺炎球菌肺炎狒狒急性肺损伤的影响。
Am J Physiol Lung Cell Mol Physiol. 2015 Oct 15;309(8):L834-46. doi: 10.1152/ajplung.00240.2015. Epub 2015 Aug 28.
9
Rates of carbon monoxide elimination in males and females.男性和女性一氧化碳的清除率。
Physiol Rep. 2014 Dec 11;2(12). doi: 10.14814/phy2.12237. Print 2014 Dec 1.
10
Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers.成年吸烟者碳氧血红蛋白浓度的群体药代动力学分析。
Br J Clin Pharmacol. 2008 Jan;65(1):30-9. doi: 10.1111/j.1365-2125.2007.02974.x. Epub 2007 Aug 31.